Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRD1 | P41143 | 6/20 | 0.58 |
| ▸ | OPRM1 | P35372 | 4/20 | 0.58 |
| ▸ | BDKRB2 | P30411 | 2/20 | 0.52 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.50 |
| ▸ | RAMP3 | O60896 | 4/20 | 0.50 |
| ▸ | CALCR | P30988 | 4/20 | 0.50 |
| ▸ | F2 | P00734 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30974525 | 0.93 | OPRM1 (0.55) | OPRD1OPRM1BDKRB2RAMP3CALCR | |
| SCHEMBL30974408 | 0.92 | OPRD1 (0.56) | OPRD1OPRM1BDKRB2SLC6A2F2 | |
| SCHEMBL30974025 | 0.91 | OPRM1 (0.58) | OPRD1OPRM1 | |
| SCHEMBL29462069 | 0.88 | OPRD1 (0.65) | OPRD1OPRM1SLC6A2F2 | |
| SCHEMBL29655865 | 0.85 | OPRD1 (0.61) | OPRD1OPRM1CALCR | |
| SCHEMBL29679769 | 0.85 | OPRD1 (0.56) | OPRD1OPRM1 | |
| SCHEMBL29679653 | 0.85 | OPRD1 (0.56) | OPRD1OPRM1 | |
| SCHEMBL29388662 | 0.84 | CALCRL (0.61) | OPRD1OPRM1CALCR | |
| SCHEMBL29656041 | 0.84 | OPRD1 (0.61) | OPRD1OPRM1CALCR | |
| SCHEMBL29376540 | 0.83 | OPRD1 (0.61) | OPRD1OPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024132726-A1 | SERUM PEPTIDE PATTERNS FOR DIAGNOSTICS OF ACUTE ISCHEMIC STROKE IN HUMANS AND DIFFERENTIAL DIAGNOSIS OF ACUTE ISCHEMIC STROKE FROM INTRACRANIAL HEMORRHAGIC STROKE | UNIWERSYTET GDANSKI (PL) | 2024-06-27 | — | — | WO | disclosed |